lobbying_activities: 1696097

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1696097	d8ad6939-3289-4a7e-ad4b-5cd1e6346168	Q2	CAPITOL HILL STRATEGIES, LLC	91774	PHRMA	2015	second_quarter	CPT	H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA)). S. 1137, Protecting American Talent and Entrepreneurship Act of 2015 (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA)).	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2015-07-15T12:10:53.847000-04:00